Malaria Endemicity: A Survey of Antimalarial Herbal Products in Ijebu Ode, Nigeria

Simple item page
dc.contributor.authorOlaniyi Afolabi Opasola, Edet Otto, Kayode Ogunyemi, and John Salami
dc.date.accessioned2025-02-08T16:32:55Z
dc.date.available2025-02-08T16:32:55Z
dc.date.issued2023-09-19
dc.descriptionThe steady rise and acceptance of herbal remedies have been empirically demonstrated in both developing and developed countries (with about 80% of the global population estimated to use herbal medicines as a primary level of care (Woo et al., 2012; Ekor, 2014; Khan & Ahmad, 2019; Mehmood et al., 2019). This trend is similarly observed in Nigeria, where herbal medical practice constitutes a fundamental component of the healthcare system for most low and middle-income populations. Herbal medicines have been extensively documented for the management of endemic diseases such as malaria (Adibe, 2009; Oreagba et al., 2011), typhoid (Bekoe et al., 2017), and other chronic ailments such as epilepsy (Danesi & Adetunji, 1994), hypertension (Amira & Okubadejo, 2007), diabetes mellitus (Ogbera et al., 2010), cancer (Fakeye et al., 2009), sickle cell anemia, and asthma (Oshikoya et al., 2008).
dc.description.abstractEmpirical evidence has shown that approximately 80% of the global population uses herbal medicines as primary care, especially in developing nations, particularly Nigeria. Despite this, an estimated 95% of global cases of malaria occur in Africa, with Nigeria accounting for approximately 27%. Therefore, the current study investigated the prevalence of antimalarial herbal medicinal products in Ijebu-Ode for the fight against malaria endemicity. It explored their regulatory registration and active plant components, considering the documented evidence of their use for treating malaria. A cross-sectional study was adopted in the collection of empirical data and analyzed in SPSS (version 23.0), while spatial data were analyzed in ARC-GIS, and the results were graphically presented using pictorial variables. The results revealed the availability of approximately 18 different antimalarial herbal products, of which 72.2% were registered with regulatory agencies. Similarly, the herbal products were shown to contain more than one plant species as their active component (Azadirachta indica (83.3%), Nauclea latifolia (55.6%), and Enantia chlorantia (44.4%), which may be responsible for multiple indications (typhoid (83.3%), yellow fever (38.9%), and cold (33.3%). The results of this study provide valuable insights for developing evidence-based policies to standardize and regulate herbal remedies, particularly for combating malaria and other endemic conditions. These findings have implications for public health and the development of effective strategies to address the challenges posed by malaria in Nigeria and other similar regions.
dc.description.sponsorshipself
dc.identifier.citationopasola et al., DUJOPAS 2023
dc.identifier.issneISSN: 2635-3490 print ISSN: 2476-8316
dc.identifier.urihttps://kwasuspace.kwasu.edu.ng/handle/123456789/4160
dc.language.isoen
dc.publisherfederal University Dutse Journal of Pure and Applied Sciences (DUJOPAS)
dc.relation.ispartofseries9 (3a)1-9; 9 (3a)1-9
dc.titleMalaria Endemicity: A Survey of Antimalarial Herbal Products in Ijebu Ode, Nigeria
dc.typeArticle
dc.typeArticle
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
001-MALARIA-ENDEMICITY-A-SURVEY-OF-ANTIMALARIAL-HERBAL-PRODUCTS-IN-IJEBU-ODE-NIGERIA (1).pdf
Size:
250.97 KB
Format:
Adobe Portable Document Format
Description:
Download
License bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed to upon submission
Description:
Download
Collections
Scholarly Publication